Cumberland Pharmaceuticals (CPIX) Total Liabilities (2016 - 2026)
Cumberland Pharmaceuticals' Total Liabilities history spans 16 years, with the latest figure at $52.3 million for Q4 2025.
- On a quarterly basis, Total Liabilities fell 1.43% to $52.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $52.3 million, a 1.43% decrease, with the full-year FY2025 number at $52.3 million, down 1.43% from a year prior.
- Total Liabilities hit $52.3 million in Q4 2025 for Cumberland Pharmaceuticals, up from $40.1 million in the prior quarter.
- Over the last five years, Total Liabilities for CPIX hit a ceiling of $57.0 million in Q4 2022 and a floor of $40.1 million in Q3 2025.
- Historically, Total Liabilities has averaged $49.3 million across 5 years, with a median of $52.3 million in 2022.
- Biggest five-year swings in Total Liabilities: soared 36.06% in 2022 and later decreased 23.43% in 2025.
- Tracing CPIX's Total Liabilities over 5 years: stood at $41.9 million in 2021, then surged by 36.06% to $57.0 million in 2022, then decreased by 7.79% to $52.5 million in 2023, then grew by 0.99% to $53.0 million in 2024, then fell by 1.43% to $52.3 million in 2025.
- Business Quant data shows Total Liabilities for CPIX at $52.3 million in Q4 2025, $40.1 million in Q3 2025, and $40.2 million in Q2 2025.